Jilin Aodong Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 5.48%

Jilin Aodong Pharmaceutical Group Co Ltd (000623) has an Asset Resilience Ratio of 5.48% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Jilin Aodong Pharmaceutical Group Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

CN¥1.89 Billion

≈ $277.17 Million USD Cash + Short-term Investments

Total Assets

CN¥34.58 Billion

≈ $5.06 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (1994–2024)

This chart shows how Jilin Aodong Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. See 000623 total equity for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Jilin Aodong Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 000623 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.89 Billion	5.48%
Total Liquid Assets	CN¥1.89 Billion	5.48%

Asset Resilience Insights

Limited Liquidity: Jilin Aodong Pharmaceutical Group Co Ltd maintains only 5.48% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Jilin Aodong Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Jilin Aodong Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Kangmei Pharmaceutical Co Ltd SHG:600518	Drug Manufacturers - Specialty & Generic	0.00%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Zhejiang Jiuzhou Pharm Co Ltd SHG:603456	Drug Manufacturers - Specialty & Generic	0.01%
Beijing Winsunny Pharmaceutical CO.LTD SHG:601089	Drug Manufacturers - Specialty & Generic	10.89%
KPC Pharmaceuticals Inc SHG:600422	Drug Manufacturers - Specialty & Generic	16.37%
Cronos Group Inc TO:CRON	Drug Manufacturers - Specialty & Generic	69.94%
Cheng Du Sheng Nuo Biotec Co. Ltd. A SHG:688117	Drug Manufacturers - Specialty & Generic	3.51%
Jiangsu Jibeier Pharmaceutical Co Ltd SHG:688566	Drug Manufacturers - Specialty & Generic	5.72%

Annual Asset Resilience Ratio for Jilin Aodong Pharmaceutical Group Co Ltd (1994–2024)

The table below shows the annual Asset Resilience Ratio data for Jilin Aodong Pharmaceutical Group Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.75%	CN¥1.57 Billion ≈ $229.46 Million	CN¥33.00 Billion ≈ $4.83 Billion	-0.39pp
2023-12-31	5.14%	CN¥1.66 Billion ≈ $242.63 Million	CN¥32.27 Billion ≈ $4.72 Billion	-0.12pp
2022-12-31	5.26%	CN¥1.64 Billion ≈ $239.96 Million	CN¥31.17 Billion ≈ $4.56 Billion	-2.27pp
2021-12-31	7.53%	CN¥2.19 Billion ≈ $320.27 Million	CN¥29.07 Billion ≈ $4.25 Billion	+2.78pp
2020-12-31	4.75%	CN¥1.30 Billion ≈ $190.24 Million	CN¥27.35 Billion ≈ $4.00 Billion	+1.24pp
2019-12-31	3.51%	CN¥906.32 Million ≈ $132.62 Million	CN¥25.80 Billion ≈ $3.78 Billion	+2.61pp
2018-12-31	0.90%	CN¥222.94 Million ≈ $32.62 Million	CN¥24.66 Billion ≈ $3.61 Billion	-0.38pp
2017-12-31	1.29%	CN¥281.44 Million ≈ $41.18 Million	CN¥21.85 Billion ≈ $3.20 Billion	-0.85pp
2016-12-31	2.14%	CN¥434.39 Million ≈ $63.57 Million	CN¥20.34 Billion ≈ $2.98 Billion	+1.22pp
2015-12-31	0.91%	CN¥181.44 Million ≈ $26.55 Million	CN¥19.83 Billion ≈ $2.90 Billion	+0.10pp
2014-12-31	0.82%	CN¥112.66 Million ≈ $16.49 Million	CN¥13.77 Billion ≈ $2.01 Billion	+0.05pp
2013-12-31	0.77%	CN¥93.07 Million ≈ $13.62 Million	CN¥12.11 Billion ≈ $1.77 Billion	+0.17pp
2012-12-31	0.60%	CN¥65.59 Million ≈ $9.60 Million	CN¥10.96 Billion ≈ $1.60 Billion	-0.02pp
2011-12-31	0.62%	CN¥62.22 Million ≈ $9.10 Million	CN¥10.08 Billion ≈ $1.48 Billion	+0.19pp
2010-12-31	0.43%	CN¥34.08 Million ≈ $4.99 Million	CN¥7.90 Billion ≈ $1.16 Billion	+0.06pp
2009-12-31	0.37%	CN¥26.65 Million ≈ $3.90 Million	CN¥7.16 Billion ≈ $1.05 Billion	-0.28pp
2008-12-31	0.65%	CN¥37.60 Million ≈ $5.50 Million	CN¥5.78 Billion ≈ $845.44 Million	+0.29pp
2007-12-31	0.37%	CN¥20.61 Million ≈ $3.02 Million	CN¥5.64 Billion ≈ $825.09 Million	+0.10pp
2006-12-31	0.27%	CN¥8.03 Million ≈ $1.17 Million	CN¥3.01 Billion ≈ $439.95 Million	+0.26pp
2005-12-31	0.01%	CN¥150.00K ≈ $21.95K	CN¥2.52 Billion ≈ $368.89 Million	-0.23pp
2002-12-31	0.24%	CN¥4.46 Million ≈ $653.25K	CN¥1.88 Billion ≈ $275.33 Million	-0.01pp
2001-12-31	0.25%	CN¥3.90 Million ≈ $570.47K	CN¥1.55 Billion ≈ $227.13 Million	-0.41pp
1999-12-31	0.66%	CN¥7.90 Million ≈ $1.16 Million	CN¥1.19 Billion ≈ $174.00 Million	+0.66pp
1994-12-31	0.00%	CN¥6.10K ≈ $892.62	CN¥215.10 Million ≈ $31.48 Million	--

pp = percentage points

About Jilin Aodong Pharmaceutical Group Co Ltd

SHE:000623 China Drug Manufacturers - Specialty & Generic

Market Cap

$3.29 Billion

CN¥22.47 Billion CNY

Market Cap Rank

#4708 Global

#880 in China

Share Price

CN¥18.79

Change (1 day)

-0.63%

52-Week Range

CN¥16.17 - CN¥21.82

All Time High

CN¥24.39